OncoSec Medical Inc. , a company developing DNA-based intratumoral cancer immunotherapies, will present at two events in December. The Company’s agenda includes high-p
from Content Keyword RSS http://ift.tt/1puUSUw
via IFTTT
from Content Keyword RSS http://ift.tt/1puUSUw
via IFTTT
No comments:
Post a Comment